Tilray Brands Inc TLRY

Alternate Symbol(s): T.TLRY

Healthcare Cannabis

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.

NDAQ:TLRY - Post by User

Tilray Brands Inc > It never ends...

<< Previous

Bullboard Posts

Next >>

Comment by ilvmyt5son Dec 08, 2021 2:06pm

115 Views

Post# 34211391

RE:It never ends...

looks like Tilray went with DOSE from the Aphria days for their instant thin films. The lawsuit is frivolous. He's a sore loser

Clowninthedark wrote:

Dr. Horst Zerbe of IntelGenx reports

INTELGENX INITIATES ARBITRATION PROCEEDING AGAINST TILRAY RELATED TO AN ALLEGED BREACH OF WORLDWIDE CANNABIS-INFUSED VERSAFILM AGREEMENT

IntelGenx Corp. has initiated an arbitration proceeding against Tilray Inc. related to an alleged breach of the parties' 2018 licence, development and supply agreement, as amended, with Tilray for the co-development and commercialization of cannabis-infused VersaFilm products.

The action follows a recent press release issued by Tilray announcing its launch of medical cannabis oral strips in THC and CBD-rich varieties based on a competitive oral thin film technology to IntelGenx's VersaFilm platform. IntelGenx believes this represents a material breach of the Agreement.

"We believe that this demonstrates a disregard of contractual obligations by Tilray. We remain committed to protecting our commercial rights and are prepared to take any necessary legal steps in that regard. Making our innovative and high-quality oral thin film products available to medical and recreational cannabis consumers remains a top priority for IntelGenx," said Dr. Horst G. Zerbe, CEO of IntelGenx.